Literature DB >> 8117438

Insufficient inactivation of HIV-1 in human cryo poor plasma by beta-propiolactone: results from a highly accurate virus detection method.

S G Norley1, J Löwer, R Kurth.   

Abstract

Human cryo poor plasma was spiked with high titre HIV-1 and subjected to a beta-propiolactone (beta-PL) inactivation procedure. The residual titre of HIV-1 was measured using a sensitive and accurate titration technique based upon the killing of MT-4 cells by HIV and the subsequent inability to incorporate 3H-thymidine. It was found that under these conditions a reduction of only 1 log virus titre was achieved after one hour exposure to beta-PL and of 1.8 logs after 5 h. The presence of viable HIV was confirmed using immunohistochemical techniques, by transfer of live virus to fresh cells, and by production of reverse transcriptase. These results have obvious implications for products where human plasma is treated with beta-PL as the only virus inactivation step.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8117438     DOI: 10.1006/biol.1993.1082

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  4 in total

1.  Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.

Authors:  B R Gundlach; S Reiprich; S Sopper; R E Means; U Dittmer; K Mätz-Rensing; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

2.  CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.

Authors:  J Ennen; H Findeklee; M T Dittmar; S Norley; M Ernst; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

3.  Effect of beta propiolactone viral inactivation on alpha1 antitrypsin values.

Authors:  S J Katona; M Bowen; E R Kaminski
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

4.  Mapping the small RNA content of simian immunodeficiency virions (SIV).

Authors:  Markus Brameier; Wiebke Ibing; Katharina Höfer; Judith Montag; Christiane Stahl-Hennig; Dirk Motzkus
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.